A Late-Stage CETP Inhibitor Developed by NewAmsterdam Pharma Company N.V. https://www.timesofupdate.com/a-late-stage-cetp-inhibitor-developed-by-newamsterdam-pharma-company-n-v/ NewAmsterdam Pharma Company N.V., a biopharmaceutical entity based in the Netherlands, is conducting late-stage clinical evaluations of obicetrapib, a novel cholesteryl ester transfer protein (CETP) inhibitor. This article explores the pharmacol… #BCAResearch #CoverageFunds #FinancialWorld #Home #NewamsterdamPharmaCompanyNV #PresidentTrump #volatility #WallStreetAnalysts